- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: recombinant human hyaluronidase (rHuPH20)
Total 25312 results
-
Thomas Jefferson UniversityJanssen Scientific Affairs, LLCActive, not recruitingPlasma Cell MyelomaUnited States
-
Halozyme TherapeuticsCompleted
-
Bristol-Myers SquibbActive, not recruitingNeoplasms by SiteUnited States, Mexico, Italy, Argentina, Brazil, Chile, France, Netherlands, New Zealand, Poland, Spain, United Kingdom
-
Halozyme TherapeuticsCompletedDermatitis, Allergic ContactUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI); Genentech, Inc.RecruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Lung Non-Small Cell Carcinoma | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung... and other conditionsUnited States
-
PfizerHalozyme TherapeuticsTerminatedHealthy | HypercholesterolemiaBelgium
-
Stanford UniversityNational Cancer Institute (NCI)TerminatedLymphedema | Malignant NeoplasmUnited States
-
Baxalta now part of ShireCompleted
-
argenxCompletedHealthy VolunteersNetherlands
-
Baxalta now part of ShireCompletedPrimary Immunodeficiency Diseases (PID)United States
-
Baxalta now part of ShireTakeda Development Center Americas, Inc.CompletedChronic Inflammatory Demyelinating PolyradiculoneuropathySpain, Canada, Poland, Italy, Serbia, Germany, Mexico, Turkey, United Kingdom, Czechia, France, United States, Argentina, Brazil, Colombia, Denmark, Greece, Slovakia
-
Halozyme TherapeuticsCompletedDiabetes Mellitus, Type 1United States
-
National Institute of Allergy and Infectious Diseases...Completed
-
Halozyme TherapeuticsCompleted
-
Halozyme TherapeuticsCompleted
-
argenxCompleted
-
Halozyme TherapeuticsBaxter Healthcare CorporationCompleted
-
Halozyme TherapeuticsCompletedDiabetes Mellitus, Type 2United States
-
Halozyme TherapeuticsCompletedRisk Factors for or a Diagnosis of OsteoporosisUnited States
-
Alexion Pharmaceuticals, Inc.Completed
-
Halozyme TherapeuticsCompleted
-
ShireHalozyme TherapeuticsCompletedHereditary AngioedemaUnited States
-
Abdullah KhanTerminatedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Recruiting
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingPlasma Cell Myeloma | RISS Stage I Plasma Cell Myeloma | RISS Stage II Plasma Cell MyelomaUnited States
-
Halozyme TherapeuticsCompletedType 1 Diabetes MellitusUnited States
-
Halozyme TherapeuticsBaxter Healthcare CorporationCompleted
-
Baxter Healthcare CorporationHalozyme TherapeuticsCompleted
-
Bristol-Myers SquibbRecruitingMelanomaUnited States, Canada, Switzerland, Italy, Spain, Australia, France, Belgium, Finland, Israel, Germany, Sweden, Argentina, Brazil, Colombia, Mexico, Norway, Chile, United Kingdom, Austria, Poland, Czechia
-
Bristol-Myers SquibbCompletedMelanomaUnited States, Australia, Belgium, Italy, Poland, Spain, United Kingdom
-
Alexion PharmaceuticalsCompletedHealthyUnited Kingdom
-
Halozyme TherapeuticsCompleted
-
TakedaTakeda Development Center Americas, Inc.RecruitingPrimary Immunodeficiency Diseases (PID)United States
-
Baxalta now part of ShireTakeda Development Center Americas, Inc.CompletedChronic Inflammatory Demyelinating PolyradiculoneuropathyUnited States, Israel, Canada, Spain, Czechia, Croatia, Poland, Italy, Serbia, Germany, Argentina, Mexico, Turkey, United Kingdom, Brazil, France, Greece, Slovakia, Colombia, Denmark, Norway, Sweden
-
Baxter Healthcare CorporationHalozyme TherapeuticsCompleted
-
UMC UtrechtUnknown
-
Baxter Healthcare CorporationHalozyme TherapeuticsTerminated
-
Janssen Research & Development, LLCCompletedMultiple MyelomaUnited States, Spain, Netherlands, Sweden, Denmark, France
-
Halozyme TherapeuticsCompleted
-
Halozyme TherapeuticsCompleted
-
Baxter Healthcare CorporationHalozyme TherapeuticsWithdrawn
-
Halozyme TherapeuticsCompletedSuperficial Bladder CancerUnited States
-
Baxter Healthcare CorporationPPD; Halozyme TherapeuticsCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnStage IV Pancreatic Cancer AJCC v8 | Metastatic Pancreatic AdenocarcinomaUnited States
-
Baxalta now part of ShireCompletedPrimary Immunodeficiency Diseases (PID)United States
-
National Cancer Institute (NCI)Recruiting
-
Janssen Research & Development, LLCCompleted
-
Bristol-Myers SquibbRecruitingMelanomaSpain, United States, Italy, Chile, Greece, Argentina
-
Baxalta now part of ShireBaxalta Innovations GmbH, now part of ShireCompleted